Reumofan Plus Tablets recall
Reumofan Plus Tablets, 30-count bottle per Box, (remaining label information in Spanish)
Why was Reumofan Plus Tablets recalled?
Marketed without an approved NDA/ANDA: Samantha Lynn Inc. is recalling Reumofan Plus Tablets because it contains undeclared drug ingredients making it an unapproved drug.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
all lots within expiry through 2016
- Product
- Reumofan Plus Tablets, 30-count bottle per Box, (remaining label information in Spanish)
- Recalling firm
- Samantha Lynn, Inc
- Quantity
- 25,888 Boxes
- Distribution
- Nationwide and Canada, Australia, Germany, Brazil, Austria, United Kingdom, India, Chile, Switzerland, Thailand, Japan
- Recall date
- December 5, 2012
- Classification
- Class I
- Status
- Terminated
- Agency
- FDA (drug)